Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

BUZZ

Pharmadrug (BUZZ)

Pharmadrug Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:CSE:BUZZ

1

Data	Hora	Fonte	Título	Código	Companhia
20/04/2021	10:41	InvestorsHub NewsWire	PHARMADRUG ADVANCES PRODUCT AND CLINICAL DEVELOPMENT OF CEPHARANTHINE TO TREAT RARE CANCERS AND INFECTIOUS DISEASES	CSE:BUZZ	Pharmadrug Inc
16/03/2021	09:10	InvestorsHub NewsWire	PHARMADRUG INITIATES DMT RESEARCH ACTIVITIES VIA COLLABORATION WITH THE UNIVERSITY OF MICHIGAN FOR FOUNDATIONAL DMT RESEARCH	CSE:BUZZ	Pharmadrug Inc
25/02/2021	10:13	InvestorsHub NewsWire	PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN KIDNEY TRANSPLANTATION AND EXPANDS ON ITS PSYCHEDELICS STRATEGY	CSE:BUZZ	Pharmadrug Inc
11/02/2021	10:18	InvestorsHub NewsWire	PHARMADRUG FILES FOR FDA ORPHAN DRUG DESIGNATION FOR DMT IN STROKE	CSE:BUZZ	Pharmadrug Inc
08/02/2021	10:00	InvestorsHub NewsWire	PHARMADRUG APPOINTS WORLD-RENOWNED DMT EXPERT DR. STEVEN A. BARKER TO ITS SCIENTIFIC ADVISORY BOARD...Cont	CSE:BUZZ	Pharmadrug Inc
04/02/2021	10:58	InvestorsHub NewsWire	PHARMADRUG SIGNS SUPPLY AGREEMENT WITH GLOBAL CANNABIS SUPPLIER AND PROVIDES UPDATE ON GERMAN OPERATIONS	CSE:BUZZ	Pharmadrug Inc
02/02/2021	10:48	InvestorsHub NewsWire	PHARMADRUG COMPLETES ACQUISITION OF SAIRIYO THERAPEUTICS INC.	CSE:BUZZ	Pharmadrug Inc
25/01/2021	11:01	InvestorsHub NewsWire	PHARMADRUG ENTERS DEFINITIVE AGREEMENT FOR ACQUISITION OF SAIRIYO THERAPEUTICS INC.	CSE:BUZZ	Pharmadrug Inc
12/01/2021	10:40	InvestorsHub NewsWire	PHARMADRUG ANNOUNCES LOI TO ACQUIRE SAIRIYO THERAPEUTICS INC	CSE:BUZZ	Pharmadrug Inc